When Nicholas Murray was awarded $1.75 million in compensatory damages over claims that Johnson & Johnson’s anti-psychotic medication Risperdal caused him to develop breast tissue, he had every reason to believe that his ordeal had finally begun to come to an end. Having been diagnosed with autism spectrum disorder, Murray’s psychiatrist put him on the medication off-label, which is to say that his ...
continue reading...J&J Facing $8 Billion Jury Award in Risperdal Decision
Posted November 27, 2019 in Drug and Medical Device Lawsuits | Product News and Recalls